Furthermore, patients treated with mastectomy presented with more high-risk features such as tumor size ≥20 mm (43.1%), positive lymph nodes (31.4%), high tumor grade (27.3%) and negative hormone receptor status (12.0%) than patients receiving BCT. The gene discussed is NR4A1; the disease is neoplasm.